Education
About Us
Working with TipRanks
Follow Us
Matthew Buten Insider Profile
11 Followers
Matthew Buten, CFO at Biohaven Pharmaceutical Holding Co, holds 193.45K shares in Biohaven Ltd. (Ticker: BHVN), holds 23.80K shares in Biohaven Pharmaceutical Holding Co (Ticker: ~BHVN).
Matthew Buten Biohaven Pharmaceutical Holding Co (~BHVN)CFO
Biohaven Pharmaceutical Holding Co (~BHVN)
CFO
Ranked #22,530 out of 100,956 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+101.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Matthew Buten holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Buten
Matthew Buten's Trading History
Biohaven Pharmaceutical Holding Co
Oct 03, 2022
―
Uninformative Sell
917.28K
$3.61M
Biohaven Ltd.
Jan 07, 2025
CFO
Uninformative Buy
65.26K
$5.78M
List of latest transactions for each holding click on a transaction to see Matthew Buten's performance on stock
You May Also Like
Matthew Buten insider profile FAQ
What is the percentage of profitable transactions made by Matthew Buten?
The percentage of profitable transactions made by Matthew Buten is 100%.
What is the average return per transaction made by Matthew Buten?
The average return per transaction made by Matthew Buten is 101.90%.
What stocks does Matthew Buten hold?
Matthew Buten holds: ~BHVN, BHVN stocks.
What was Matthew Buten’s latest transaction?
Matthew Buten latest transaction was an Uninformative Buy of $65.26K.
What was Matthew Buten's most profitable transaction?
Matthew Buten’s most profitable transaction was an Informative Buy of BHVN stock on October 26, 2022. The return on the trade was 105.60%.
What is Matthew Buten's role in Biohaven Pharmaceutical Holding Co?
Matthew Buten's role in Biohaven Pharmaceutical Holding Co is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.